Laguitao, Jeannevive M.

HRN: 04-59-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2025
CEFUROXIME 500MG (TAB)
08/19/2025
08/26/2025
PO
500mg
BID
SP TAHRS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines